(Q73835678)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10832100%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

title

Apolipoprotein-mediated cellular cholesterol/phospholipid efflux and plasma high density lipoprotein level in mice (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10832100%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10832100%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

author name string

S Tomimoto

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10832100%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

K Okumura-Noji

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10832100%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

M Okazaki

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10832100%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

S Yokoyama

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10832100%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

language of work or name

English

0 references

publication date

1 May 2000

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10832100%20AND%20SRC:MED&resulttype=core&format=json

Biochimica et Biophysica Acta

7 November 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10832100%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

volume

1485

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10832100%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

issue

2-3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10832100%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

page(s)

199-213

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10832100%20AND%20SRC:MED&resulttype=core&format=json

Lack of apoA-I is not associated with increased susceptibility to atherosclerosis in mice

7 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1388-1981%2800%2900061-5

7 January 2021

Low-dose expression of a human apolipoprotein E transgene in macrophages restores cholesterol efflux capacity of apolipoprotein E-deficient mouse plasma

1 reference

https://api.crossref.org/works/10.1016%2FS1388-1981%2800%2900061-5

7 January 2021

Targeted mutation of plasma phospholipid transfer protein gene markedly reduces high-density lipoprotein levels

1 reference

https://api.crossref.org/works/10.1016%2FS1388-1981%2800%2900061-5

7 January 2021

Targeted disruption of the mouse lecithin:cholesterol acyltransferase (LCAT) gene. Generation of a new animal model for human LCAT deficiency.

1 reference

https://api.crossref.org/works/10.1016%2FS1388-1981%2800%2900061-5

7 January 2021

Disruption of the murine lecithin:cholesterol acyltransferase gene causes impairment of adrenal lipid delivery and up-regulation of scavenger receptor class B type I.

1 reference

https://api.crossref.org/works/10.1016%2FS1388-1981%2800%2900061-5

7 January 2021

Overexpression of the HDL receptor SR-BI alters plasma HDL and bile cholesterol levels

1 reference

https://api.crossref.org/works/10.1016%2FS1388-1981%2800%2900061-5

7 January 2021

Synthetic amphipathic helical peptides that mimic apolipoprotein A-I in clearing cellular cholesterol

1 reference

https://api.crossref.org/works/10.1016%2FS1388-1981%2800%2900061-5

7 January 2021

Apolipoprotein E produced by human monocyte-derived macrophages mediates cholesterol efflux that occurs in the absence of added cholesterol acceptors

1 reference

https://api.crossref.org/works/10.1016%2FS1388-1981%2800%2900061-5

7 January 2021

Apolipoprotein-mediated cellular cholesterol efflux

1 reference

https://api.crossref.org/works/10.1016%2FS1388-1981%2800%2900061-5

7 January 2021

Defective removal of cellular cholesterol and phospholipids by apolipoprotein A-I in Tangier Disease

1 reference

https://api.crossref.org/works/10.1016%2FS1388-1981%2800%2900061-5

7 January 2021

Decreased reverse cholesterol transport from Tangier disease fibroblasts. Acceptor specificity and effect of brefeldin on lipid efflux

1 reference

https://api.crossref.org/works/10.1016%2FS1388-1981%2800%2900061-5

7 January 2021

Mutations in ABC1 in Tangier disease and familial high-density lipoprotein deficiency

1 reference

https://api.crossref.org/works/10.1016%2FS1388-1981%2800%2900061-5

7 January 2021

The gene encoding ATP-binding cassette transporter 1 is mutated in Tangier disease

1 reference

https://api.crossref.org/works/10.1016%2FS1388-1981%2800%2900061-5

7 January 2021

Tangier disease is caused by mutations in the gene encoding ATP-binding cassette transporter 1

1 reference

https://api.crossref.org/works/10.1016%2FS1388-1981%2800%2900061-5

7 January 2021

Human ATP-binding cassette transporter 1 (ABC1): genomic organization and identification of the genetic defect in the original Tangier disease kindred

1 reference

https://api.crossref.org/works/10.1016%2FS1388-1981%2800%2900061-5

7 January 2021

The Tangier disease gene product ABC1 controls the cellular apolipoprotein-mediated lipid removal pathway

1 reference

https://api.crossref.org/works/10.1016%2FS1388-1981%2800%2900061-5

7 January 2021

Selective inhibition of free apolipoprotein-mediated cellular lipid efflux by probucol

1 reference

https://api.crossref.org/works/10.1016%2FS1388-1981%2800%2900061-5

7 January 2021

Induction of cellular cholesterol efflux to lipid-free apolipoprotein A-I by cAMP.

1 reference

https://api.crossref.org/works/10.1016%2FS1388-1981%2800%2900061-5

7 January 2021

A little more information about aggravation of probucol-induced HDL-reduction by clofibrate

1 reference

https://api.crossref.org/works/10.1016%2FS1388-1981%2800%2900061-5

7 January 2021

Comparison of gas chromatography and high-performance liquid chromatography for the analysis of probucol in plasma

1 reference

https://api.crossref.org/works/10.1016%2FS1388-1981%2800%2900061-5

7 January 2021

Oxidative tyrosylation of HDL enhances the depletion of cellular cholesteryl esters by a mechanism independent of passive sterol desorption

1 reference

https://api.crossref.org/works/10.1016%2FS1388-1981%2800%2900061-5

7 January 2021

Efficient Trace-labelling of Proteins with Iodine

1 reference

https://api.crossref.org/works/10.1016%2FS1388-1981%2800%2900061-5

7 January 2021

Purification, characterization, and conformational analysis of rabbit plasma lipid transfer protein

1 reference

https://api.crossref.org/works/10.1016%2FS1388-1981%2800%2900061-5

7 January 2021

Transport of HDL cholesterol esters to the liver is not diminished by probucol treatment in rats.

1 reference

https://api.crossref.org/works/10.1016%2FS1388-1981%2800%2900061-5

7 January 2021

Metabolism of High-Density Lipoprotein Apolipoproteins in Tangier Disease

1 reference

https://api.crossref.org/works/10.1016%2FS1388-1981%2800%2900061-5

7 January 2021

Tangier disease. High density lipoprotein deficiency due to defective metabolism of an abnormal apolipoprotein A-i (ApoA-ITangier)

1 reference

https://api.crossref.org/works/10.1016%2FS1388-1981%2800%2900061-5

7 January 2021

Increased apo A-I and apo A-II fractional catabolic rate in patients with low high density lipoprotein-cholesterol levels with or without hypertriglyceridemia

1 reference

https://api.crossref.org/works/10.1016%2FS1388-1981%2800%2900061-5

7 January 2021

Human HDL cholesterol levels are determined by apoA-I fractional catabolic rate, which correlates inversely with estimates of HDL particle size. Effects of gender, hepatic and lipoprotein lipases, triglyceride and insulin levels, and body fat distri

1 reference

https://api.crossref.org/works/10.1016%2FS1388-1981%2800%2900061-5

7 January 2021

Familial HDL deficiency characterized by hypercatabolism of mature apoA-I but not proapoA-I

1 reference

https://api.crossref.org/works/10.1016%2FS1388-1981%2800%2900061-5

7 January 2021

Probucol enhances selective uptake of HDL-associated cholesteryl esters in vitro by a scavenger receptor B-I-dependent mechanism

1 reference

https://api.crossref.org/works/10.1016%2FS1388-1981%2800%2900061-5

7 January 2021

Mechanisms of HDL reduction after probucol. Changes in HDL subfractions and increased reverse cholesteryl ester transfer

1 reference

https://api.crossref.org/works/10.1016%2FS1388-1981%2800%2900061-5

7 January 2021

Effects of probucol on xanthomata regression in familial hypercholesterolemia

1 reference

https://api.crossref.org/works/10.1016%2FS1388-1981%2800%2900061-5

7 January 2021

Probucol prevents the progression of atherosclerosis in Watanabe heritable hyperlipidemic rabbit, an animal model for familial hypercholesterolemia

1 reference

https://api.crossref.org/works/10.1016%2FS1388-1981%2800%2900061-5

7 January 2021

Inhibition of hypercholesterolemia-induced atherosclerosis in the nonhuman primate by probucol. I. Is the extent of atherosclerosis related to resistance of LDL to oxidation?

1 reference

https://api.crossref.org/works/10.1016%2FS1388-1981%2800%2900061-5

7 January 2021

Probucol and multivitamins in the prevention of restenosis after coronary angioplasty. Multivitamins and Probucol Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS1388-1981%2800%2900061-5

7 January 2021

Paradoxical enhancement of atherosclerosis by probucol treatment in apolipoprotein E-deficient mice

1 reference

https://api.crossref.org/works/10.1016%2FS1388-1981%2800%2900061-5

7 January 2021

Antiatherogenic effects of the antioxidant BO-653 in three different animal models.

1 reference

https://api.crossref.org/works/10.1016%2FS1388-1981%2800%2900061-5

7 January 2021

Lowering of HDL 2b by Probucol Partly Explains the Failure of the Drug to Affect Femoral Atherosclerosis in Subjects With Hypercholesterolemia

1 reference

https://api.crossref.org/works/10.1016%2FS1388-1981%2800%2900061-5

7 January 2021

Role of apolipoproteins in cholesterol efflux from macrophages to lipid microemulsion: proposal of a putative model for the pre-beta high-density lipoprotein pathway

1 reference

https://api.crossref.org/works/10.1016%2FS1388-1981%2800%2900061-5

7 January 2021

Alpha-helical requirements for free apolipoproteins to generate HDL and to induce cellular lipid efflux

1 reference

https://api.crossref.org/works/10.1016%2FS1388-1981%2800%2900061-5

7 January 2021

Cholesterol is poorly available for free apolipoprotein-mediated cellular lipid efflux from smooth muscle cells.

1 reference

https://api.crossref.org/works/10.1016%2FS1388-1981%2800%2900061-5

7 January 2021

Selective down-regulation by protein kinase C inhibitors of apolipoprotein-mediated cellular cholesterol efflux in macrophages

1 reference

https://api.crossref.org/works/10.1016%2FS1388-1981%2800%2900061-5

7 January 2021

10.1016/S1388-1981(00)00061-5

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10832100%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

1 reference